Limited Offer
Treatment of Skin Disease
Comprehensive Therapeutic Strategies
- 6th Edition - September 17, 2021
- Authors: Mark Lebwohl, Ian H. Coulson, Dedee Murrell
- Editor: Warren R. Heymann
- Language: English
- Hardback ISBN:9 7 8 - 0 - 7 0 2 0 - 8 2 1 0 - 8
- eBook ISBN:9 7 8 - 0 - 7 0 2 0 - 8 2 1 1 - 5
Covering nearly 260 of the most common dermatologic conditions from A to Z, Treatment of Skin Disease, 6th Edition, by Drs. Mark G. Lebwohl, Warren R. Heymann, Ian Coulson, and D… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteCovering nearly 260 of the most common dermatologic conditions from A to Z, Treatment of Skin Disease, 6th Edition, by Drs. Mark G. Lebwohl, Warren R. Heymann, Ian Coulson, and Dedee Murrell, is your go-to resource for authoritative, evidence-based treatment strategies in your daily practice. This award-winning text provides guidance on the fast-moving dermatological therapy options for virtually any skin disease you’re likely to encounter, including third-line and unusual therapies when initial options have not been successful. Summaries of each treatment strategy are accompanied by detailed discussions of treatment choices, with ratings on a consistent scale ranging from clinical studies to anecdotal reports.
- Cover image
- Title page
- Table of Contents
- Copyright
- Preface
- List of Contributors
- Acknowledgments
- Dedication
- Evidence Levels
- Credits
- Treatment of Skin Disease Previous Edition Contributors
- 1. Acanthosis nigricans
- Management Strategy
- 2. Acne keloidalis nuchae
- Management Strategy
- 3. Acne vulgaris
- Management Strategy
- 4. Acrodermatitis enteropathica
- Management Strategy
- 5. Actinic keratosis
- Management Strategy
- 6. Actinic prurigo: (Synonyms: hereditary polymorphic light eruption of American Indians, Hutchinson summer prurigo, photodermatitis in North American Indians)
- Management Strategy
- 7. Actinomycosis
- Management Strategy
- Specific Investigations
- 8. Acute generalized exanthematous pustulosis
- Management Strategy
- 9. Allergic contact dermatitis and photoallergy
- Management Strategy
- 10. Alopecia areata
- Management Strategy
- 11. Amyloidosis
- Management Strategy
- 12. Androgenetic alopecia
- Management Strategy
- 13. Angiolymphoid hyperplasia with eosinophilia
- Management Strategy
- 14. Angular cheilitis
- Management Strategy
- 15. Antiphospholipid syndrome
- Management Strategy
- 16. Aphthous stomatitis
- Management Strategy
- 17. Atopic dermatitis
- Management Strategy
- 18. Atypical fibroxanthoma
- Management Strategy
- 19. Atypical nevi
- Management Strategy
- 20. Autoimmune progesterone dermatitis
- Management Strategy
- 21. Bacillary angiomatosis
- Management Strategy
- 22. Balanitis
- Management Strategy
- 23. Basal cell carcinoma
- Management Strategy
- 24. Becker nevus
- Management Strategy
- 25. Bed bugs
- Management Strategy
- 26. Behçet disease
- Management Strategy
- 27. Bites and stings
- Management Strategy
- 28. Blastomycosis
- Management Strategy
- Guidelines
- 29. Blistering distal dactylitis
- Management Strategy
- 30. Body dysmorphic disorder (dermatologic non-disease): Synonyms: Dermatologic non-disease, Body dysmorphic disease, Dysmorphophobia
- Management Strategy
- 31. Bowen disease and erythroplasia of Queyrat
- Introduction
- Diagnosis
- Management Strategy
- 32. Bullous pemphigoid
- Management Strategy
- Therapies
- 33. Burning mouth syndrome (glossodynia)
- Management Strategy
- 34. Calcinosis cutis
- Management Strategy
- 35. Calciphylaxis
- Management Strategy
- 36. Capillaritis (pigmented purpuric dermatoses, purpura pigmentosa)
- Management Strategy
- 37. Cat scratch disease
- Management Strategy
- 38. Cellulite
- Management Strategy
- 39. Cellulitis and erysipelas
- Management Strategy
- 40. Chancroid
- Diagnosis and Management Strategy
- 41. Chilblains
- Management Strategy
- 42. Chondrodermatitis nodularis helicis chronicus
- Management Strategy
- 43. Chromoblastomycosis
- Management Strategy
- 44. Chronic actinic dermatitis
- Management Strategy
- 45. Coccidioidomycosis
- Management Strategy
- 46. Condyloma acuminata
- Management Strategy
- 47. COVID-19 dermatoses
- COVID-19 Related Rashes In Adults
- Pediatric Multisystem Inflammatory Syndrome
- 48. Cryopyrin-associated periodic syndrome (CAPS)
- Management Strategy
- 49. Cryptococcosis
- Management Strategy
- 50. Cutaneous candidiasis and chronic mucocutaneous candidiasis
- Cutaneous Candidiasis
- Management Strategy
- Chronic Mucocutaneous Candidiasis
- Management Strategy
- 51. Cutaneous larva migrans
- Management Strategy
- 52. Cutaneous polyarteritis nodosa
- Management Strategy
- 53. Darier disease
- Management Strategy
- 54. Decubitus (pressure) ulcers
- Management Strategy
- 55. Delusions of parasitosis
- Management Strategy
- 56. Dermatitis artefacta
- Management Strategy
- 57. Dermatitis herpetiformis
- Management Strategy
- 58. Dermatofibrosarcoma protuberans
- Management Strategy
- 59. Dermatomyositis
- Management Strategy
- 60. Diaper dermatitis
- Management Strategy
- 61. Discoid (nummular) eczema
- Management Strategy
- 62. Discoid lupus erythematosus
- Management Strategy
- 63. Dissecting cellulitis of the scalp
- Management Strategy
- 64. Dress syndrome: drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DiHS)
- Management Strategy
- 65. Drug eruptions
- Management Strategy
- 66. Eosinophilic fasciitis
- Management Strategy
- 67. Epidermal nevi
- Management Strategy
- 68. Epidermodysplasia verruciformis
- Management Strategy
- 69. Epidermolysis bullosa
- Management Strategy
- 70. Epidermolysis bullosa acquisita
- Management Strategy
- 71. Erosive pustular dermatosis
- Management Strategy
- 72. Erythema annulare centrifugum
- Background
- Diagnosis/Management Strategy
- 73. Erythema dyschromicum perstans
- Management Strategy
- 74. Erythema elevatum diutinum
- Management Strategy
- 75. Erythema multiforme
- Management Strategy
- 76. Erythema nodosum
- Management Strategies
- 77. Erythrasma
- Management Strategy
- 78. Erythroderma
- Management Strategy
- 79. Erythrokeratodermas
- Management Strategy
- 80. Erythromelalgia
- Management Strategy
- 81. Erythropoietic protoporphyria
- Management Strategy
- 82. Extramammary Paget disease
- Management Strategy
- 83. Fabry disease
- Management Strategy
- 84. Flushing
- Management Strategy
- 85. Follicular mucinosis
- Management Strategy
- 86. Folliculitis
- Management Strategy
- 87. Folliculitis decalvans
- Management Strategy
- 88. Fox–Fordyce disease
- Management Strategy
- 89. Furunculosis
- Management Strategy
- 90. Geographic tongue
- Management Strategy
- 91. Gianotti–Crosti syndrome
- Management Strategy
- 92. Gonorrhea
- Management Strategy
- Special Considerations
- 93. Graft-versus-host disease
- Management Strategy
- Acute Gvhd
- Chronic Gvhd
- 94. Granuloma annulare
- Management Strategy
- Localized Granuloma Annulare
- Generalized (Disseminated) Granuloma Annulare
- 95. Granuloma faciale
- Management Strategy
- 96. Granuloma inguinale
- Management Strategy
- Special Considerations
- 97. Granulomatous cheilitis
- Management Strategy
- 98. Hailey–Hailey disease
- Management Strategy
- 99. Hand and foot eczema (endogenous, dyshidrotic eczema, pompholyx)
- Management Strategy
- 100. Hemangiomas
- Management Strategy
- 101. Hereditary angioedema
- Management Strategy
- Acute Angioedema
- Long-Term Prophylaxis
- Short-Term Prophylaxis (STP) for Prevention of Relapse Due to Dental and Surgical Interventions
- Acute Angioedema
- Long-Term Prophylaxis
- Short-Term Prophylaxis
- Treatment in Children
- Hereditary Angioedema with Normal C1-INH
- 102. Hereditary hemorrhagic telangiectasia
- Management Strategy
- 103. Herpes genitalis
- Management Strategy
- Novel and Other Therapies
- Prevention
- 104. Herpes labialis
- Management Strategy
- Other Therapies
- 105. Herpes zoster
- Management Strategy
- 106. Hidradenitis suppurativa
- Management Strategy
- 107. Histoplasmosis
- Management Strategy
- 108. Hydroa vacciniforme
- Management Strategy
- 109. Hyperhidrosis
- Management Strategy
- 110. Hypertrichosis and hirsutism
- Introduction
- Management Strategy
- 111. Hypopigmented disorders
- Management Strategy
- 112. Ichthyoses
- Management Strategy
- 113. Impetigo
- Management Strategy
- 114. Inducible urticarias, aquagenic pruritus, and cholinergic pruritus
- Inducible Urticarias
- Symptomatic Dermographism
- Cholinergic Urticaria
- Cold Urticaria
- Heat Urticaria
- Delayed Pressure Urticaria
- Solar Urticaria
- Aquagenic Pruritus
- Cholinergic Pruritus
- 115. Irritant contact dermatitis
- Management Strategy
- 116. Jellyfish stings
- Clinical and Demographic Features
- Cutaneous Manifestations of Jellyfish Stings
- Management Strategy
- 117. Jessner lymphocytic infiltrate
- Management Strategy
- 118. Juvenile plantar dermatosis
- Management Strategy
- 119. Juvenile xanthogranuloma
- Management Strategy
- 120. Kaposi sarcoma
- Management Strategy
- 121. Kawasaki disease
- Management Strategies
- Kawasaki Disease: an Overview
- Kawasaki Disease: an Update on Treatment
- 122. Keloids
- Management Strategy
- 123. Keratoacanthoma
- Management Strategy
- 124. Keratosis lichenoides chronica
- Introduction
- Management Strategy
- 125. Keratosis pilaris and variants
- Management Strategy
- 126. Langerhans cell histiocytosis
- Management Strategy
- 127. Leg ulcers
- Management Strategy
- 128. Leiomyoma
- Management Strategy
- 129. Leishmaniasis
- Management Strategy
- 130. Lentigo maligna
- Management Strategy
- 131. Leprosy (including reactions)
- Management Strategy
- 132. Leukocytoclastic vasculitis (cutaneous small vessel vasculitis)
- Management Strategy
- 133. Lichen myxedematosus
- Management Strategy
- 134. Lichen nitidus
- Management Strategy
- 135. Lichen planopilaris
- Management Strategy
- 136. Lichen planus
- Management Strategy
- 137. Lichen sclerosus
- Management Strategy
- 138. Lichen simplex chronicus
- Management Strategy
- 139. Linear IgA bullous dermatosis
- Management Strategy
- 140. Lipodermatosclerosis
- Management Strategy
- 141. Livedo reticularis
- Management Strategy
- 142. Livedoid vasculopathy
- Management Strategy
- 143. Lyme borreliosis
- Management Strategy
- Specific Investigations
- 144. Lymphangioma circumscriptum
- Management Strategies
- 145. Lymphedema
- Management Strategies
- 146. Lymphocytoma cutis
- Management Strategy
- 147. Lymphogranuloma venereum
- Management Strategy
- 148. Lymphomatoid papulosis
- Management Strategy
- 149. Malignant atrophic papulosis
- Management Strategy
- 150. Malignant melanoma
- Management Strategy
- 151. Mastocytoses
- Management Strategy
- 152. Melasma
- Management Strategy
- 153. Merkel cell carcinoma
- Introduction
- Management Strategy
- 154. Methicillin-resistant Staphylococcus aureus (MRSA)
- Management Strategy
- Specific Investigations
- 155. Miliaria
- Management Strategy
- 156. Molluscum contagiosum
- Management Strategy
- 157. Morphea
- Management Strategy
- 158. Mucoceles
- Management Strategy
- 159. Mucous membrane pemphigoid
- Management Strategy
- 160. Mycetoma: Eumycetoma and actinomycetoma
- Management Strategy
- 161. Mycobacterial (atypical) skin infections
- Mycobacterium Marinum
- Rapidly Growing Mycobacteria
- Mycobacterium Ulcerans
- 162. Mycosis fungoides and Sézary syndrome
- Management Strategy
- 163. Myiasis
- Management Strategy
- 164. Myxoid cyst
- Management Strategy
- 165. Nail psoriasis
- Management Strategy
- 166. Necrobiosis lipoidica
- Management Strategy
- 167. Necrolytic acral erythema
- Management Strategy
- 168. Necrolytic migratory erythema
- Management Strategy
- 169. Neurofibromatosis, type 1
- Management Strategy
- 170. Nevoid basal cell carcinoma syndrome (Gorlin syndrome)
- Management Strategy
- 171. Nevus sebaceus
- Management Strategy
- 172. Notalgia paresthetica
- Management Strategy
- 173. Onchocerciasis
- Management Strategy
- 174. Oral lichen planus
- Management Strategy
- 175. Orf
- Management Strategy
- 176. Palmoplantar keratoderma
- Management Strategy
- 177. Palmoplantar pustulosis
- Management Strategy
- 178. Panniculitis
- Management Strategy
- Lupus Panniculitis
- Nodular Vasculitis
- Pancreatic Panniculitis
- Cytophagic Histiocytic Panniculitis
- α1-Antitrypsin Deficiency Panniculitis
- 179. Papular urticaria
- Management Strategy
- 180. Paracoccidioidomycosis
- Management Strategy
- 181. Parapsoriasis
- Management Strategy
- Small Plaque Parapsoriasis
- Large Plaque Parapsoriasis
- 182. Paronychia
- Management Strategy
- 183. Parvovirus infection
- Management Strategy
- 184. Pediculosis
- Pediculosis Capitis
- Pediculosis Corporis
- Pediculosis Pubis
- Phthiriasis Palpebrarum
- 185. Pemphigus
- Management Strategy
- 186. Perforating dermatoses
- Management Strategy
- 187. Perioral dermatitis
- Management Strategy
- 188. Peutz–Jeghers syndrome
- Management Strategy
- 189. Pinta and yaws
- 190. Pitted and ringed keratolysis (keratolysis plantare sulcatum)
- Management Strategy
- 191. Pityriasis lichenoides chronica
- Management Strategy
- 192. Pityriasis lichenoides et varioliformis acuta
- Management Strategy
- 193. Pityriasis rosea
- Management Strategy
- 194. Pityriasis rubra pilaris
- Management Strategy
- Systematic Reviews
- 195. Polycystic ovary syndrome
- Management Strategy
- 196. Polymorphic light eruption
- Management Strategy
- 197. Porokeratoses
- Management Strategy
- 198. Porphyria cutanea tarda
- Management Strategy
- 199. Port wine stain (‘nevus flammeus’)
- Management Strategy
- 200. Postinflammatory hyperpigmentation and other disorders of hyperpigmentation
- Introduction
- Postinflammatory Hyperpigmentation
- Other Disorders of Hyperpigmentation
- Management Strategy
- 201. Pregnancy dermatoses
- Polymorphic Eruption of Pregnancy
- Pemphigoid Gestationis
- Intrahepatic Cholestasis Of Pregnancy
- Atopic Eruption Of Pregnancy
- 202. Pretibial myxedema
- Management Strategy
- 203. Prurigo nodularis
- Management Strategy
- 204. Prurigo pigmentosa
- Management Strategy
- 205. Pruritus
- Introduction
- Management Strategy
- Chronic Pruritus of Unknown Origin (CPUO)
- Itch in Dermatologic Diseases
- Systemic Causes of Chronic Itch
- Treatment of Itch in Special Populations
- 206. Pruritus ani
- Management Strategy
- 207. Pruritus vulvae
- Management Strategy
- Situational Treatment Considerations
- Select Publications on Etiology and Management
- 208. Pseudofolliculitis barbae
- Introduction
- Management Strategy
- 209. Pseudoxanthoma elasticum
- Management Strategy
- 210. Psoriasis
- Management Strategy
- Guttate Psoriasis
- Inverse Psoriasis
- Erythrodermic Psoriasis
- Generalized Pustular Psoriasis
- 211. Psychogenic excoriation
- Management Strategy
- 212. Pyoderma gangrenosum
- Management Strategy
- 213. Pyogenic granuloma
- Management Strategy
- 214. Radiation dermatitis
- Management Strategy
- 215. Raynaud disease and phenomenon
- Management Strategy
- 216. Reactive arthritis
- Management Strategy
- 217. Relapsing polychondritis
- Management Strategy
- 218. Rhinophyma
- Management Strategy
- 219. Rocky Mountain spotted fever and other rickettsial infections
- Rickettsial Spotted Fevers
- Typhus Group
- Rickettsialpox
- Q Fever
- Ehrlichiosis
- 220. Rosacea
- Management Strategy
- Papulopustular Rosacea
- Persistent Facial Erythema (Erythematotelangiectatic Rosacea)
- Flushing of Rosacea
- Rosacea Lymphedema (Morbihan Disease)
- Ocular Rosacea
- Rosacea Fulminans/Pyoderma Faciale
- 221. Sarcoidosis
- Management Strategy
- 222. Scabies
- Management Strategy
- General Management Considerations
- 223. Scleredema
- Management Strategy
- 224. Scleroderma (systemic sclerosis)
- Management Strategy
- 225. Sebaceous gland hyperplasia
- Management Strategy
- 226. Seborrheic eczema
- Management Strategy
- Non-Scalp Disease
- Scalp Disease
- 227. Seborrheic keratosis
- Management Strategy
- 228. Sporotrichosis
- Management Strategy
- 229. Squamous cell carcinoma
- Management Strategy
- 230. Staphylococcal scalded skin syndrome
- Management Strategy
- 231. Steatocystoma multiplex
- Management Strategy
- 232. Stoma care
- Management Strategy
- 233. Striae
- Management Strategy
- 234. Subacute cutaneous lupus erythematosus
- Management Strategy
- 235. Subcorneal pustular dermatosis
- Management Strategy
- 236. Subcutaneous fat necrosis of the newborn
- Management Strategy
- Surgical Management
- 237. Sweet syndrome
- Management Strategy
- 238. Syphilis
- Management Strategy
- Diagnostics and Treatment
- 239. Syringomata
- Management Strategy
- 240. Tinea capitis
- Management Strategy
- 241. Tinea corporis and tinea cruris
- Management Strategy
- 242. Tinea pedis
- Management Strategy
- 243. Tinea unguium
- Management Strategy
- 244. Tinea versicolor (pityriasis versicolor)
- Management Strategy
- 245. Toxic epidermal necrolysis and Stevens–Johnson syndrome
- Management Strategy
- 246. Transient acantholytic dermatosis (Grover disease)
- Management Strategy
- 247. Trichotillomania
- Diagnosis
- Management Strategy
- 248. Tuberculosis (cutaneous) and tuberculids
- Clinical Features
- Management Strategy
- Treatment
- 249. Urticaria and angioedema
- Urticaria
- Management Strategy
- Non-Mast Cell–Mediated Angioedema
- Management Strategy for Bradykinin-Mediated Angioedema
- 250. Varicella
- Management Strategy
- 251. Viral exanthems: Rubella, roseola, rubeola and enteroviruses
- Rubella
- Management Strategy
- Roseola
- Management Strategy
- Rubeola
- Management Strategy
- Enteroviruses
- Management Strategy
- 252. Vitiligo
- Management Strategy
- Emerging Treatments
- 253. Vulvodynia
- Introduction
- Management Strategy
- Specific Investigations
- 254. Warts
- Management Strategy
- 255. Wells syndrome
- Management Strategy
- 256. Xanthomas
- Management Strategy
- 257. Xeroderma pigmentosum
- Management Strategy
- 258. Xerosis
- Management Strategy
- 259. Yellow nail syndrome
- Management Strategy
- Index
- No. of pages: 964
- Language: English
- Edition: 6
- Published: September 17, 2021
- Imprint: Elsevier
- Hardback ISBN: 9780702082108
- eBook ISBN: 9780702082115
WH
Warren R. Heymann
Affiliations and expertise
Professor of Medicine and Pediatrics, Head, Division of Dermatology, Cooper Medical School of Rowan University, Camden, NJ, USA
Clinical Professor of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ML
Mark Lebwohl
Mark G. Lebwohl, MD, FAAD
Chairman Emeritus
Kimberly and Eric J. Waldman Department of Dermatology
Dean for Clinical Therapeutics
Icahn School of Medicine at Mount Sinai
New York, NY, USA
IC
Ian H. Coulson
Ian H. Coulson, BSc, MB, FRCP
Consultant Dermatologist
The Beardwood Hospital
Blackburn
Lancashire
BB2 7AE
DM
Dedee Murrell
Dedee F. Murrell MA, BM, MD, FACD, FRCP
Professor, Faculty of Medicine, UNSW Medical School, Sydney, Australia Head, Dept of Dermatology, St George Hospital Campus, Kogarah, Sydney, Australia
Professorial Fellow (Honorary), The George Institute for Global Health, Sydney